Louisiana Research Associates

New Orleans, Louisiana 70114

0 studies enrolling now · 15 studies all time

What they study most

ADHD, Alzheimer Disease, Alzheimer's Disease, Anxiety Disorders, Cancer, Cancer Pain, Epilepsy, Obsessive-Compulsive Disorder, Opioid Dependence, Opioid Related Disorders, Opioid Use Disorder, Opioid-related Disorders

Studies at this site

• A Study of Gantenerumab in Participants With Mild Alzheimer Disease — Completed
• A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab — Completed
• An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery — Completed
• Open-Label Treatment Extension Study — Completed
• Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder — Completed
• Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine — Completed
• Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy — Completed
• A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD) — Completed
• A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY) — Completed
• A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy — Completed
• Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD — Completed
• Gene Transfer for Cancer Pain — Completed
• A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. — Completed
• 18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type — Completed
• A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD) — Completed